Risk analysis of hepatocellular carcinoma in Northeast China

  • Zhi-fang Jia
  • Meng Su
  • Miao He
  • Zhi-hua Yin
  • Wei Wu
  • Xue-lian Li
  • Peng Guan
  • Bao-sen Zhou
Liver Cancer
  • 25 Downloads

Abstract

Objective

It is known that chronic hepatitis B virus (HBV) infection is a main risk factor for hepatocellular carcinoma (HCC). To assess the effect of HBV infection and its interaction with other factors on the risk for HCC, a hospital-based case-control study was carried out in Northeast China.

Methods

A total of 384 cases with hepatocellular carcinoma and 432 controls without evidence of liver diseases were enrolled in the study. Blood samples were collected to detect the serum markers of hepatitis B virus (HBV) and hepatitis C virus (HCV) and questionnaires about lifestyle and family tumor history were performed in all subjects.

Results

The total infection rate of HBV in hepatocellular carcinoma cases was 70.8% and 10.0% in non-liver disease controls. There was a statistically significant difference (P<0.0001) between cases and controls (OR= 22.0; 95%CI:15.0–32.3). Interaction analysis indicated that in HBV chronic carriers with HCV infection or alcohol consumption or family HCC history, the risk for HCC increased (OR=41.1, 95%CI: 20.2–83.9, OR=125.0, 95%CI: 66.5–235.2; OR=56.9, 95%CI: 27.2–119.3 respectively). In addition, hepatitis B history, HCV infection, hepatic cirrhosis and family history of HCC were also potential HCC independent risk factors.

Conclusion

We confirmed that HBV is a chief risk factor for hepatocellular carcinoma and accounts for 67.7% of all hepatocellular carcinoma in Northeast China. HCV infection, alcohol intake and family history could enhance the risk for HCC in chronic HBV carriers.

Key Words

Hepatitis B virus Hepatocellular carcinoma Risk factors 

CLC number

R735.7 

References

  1. [1]
    Lloved JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects[J]. J Hepatol 2003; 38: S136–S149.CrossRefGoogle Scholar
  2. [2]
    Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin 2005; 55: 74–108.CrossRefPubMedGoogle Scholar
  3. [3]
    Cai L, Binh G, Parkin D, et al. Cancer Trends in Asian Pacific rim region[J]. Tumor(in Chinese) 2004; 24: 422–426.Google Scholar
  4. [4]
    Jing LB, Yu GH, Guo CS, et al. An analysis of cancer incidence and mortality in some cities, Liaoning Province[J]. Bull Chin Cancer (in Chinese) 2003; 12: 393–394.Google Scholar
  5. [5]
    Lin MJ, Dai XD Sun XW, et al. The incidence and mortality analysis malignancies in 1995 and 2000 year in major cities of Heilongjiang Province[J]. Bull Chin Cancer (in Chinese) 2002; 11: 29–30.Google Scholar
  6. [6]
    Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma[J]. Gastroenterology 2004; 127: S72–S78.CrossRefPubMedGoogle Scholar
  7. [7]
    IARC Monographs. Hepatitis Viruses[M]. Vol. 59. Lyon: IARC Press. 1994; 72–97.Google Scholar
  8. [8]
    Sun ZT, Ming LH, Zhu X, et al. Prevention and control of hepatitis B in China[J]. J Med Virol 2002; 67: 447–450.CrossRefPubMedGoogle Scholar
  9. [9]
    Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine preention[J]. J Clin Virol 2005; 34: S1–S3.CrossRefPubMedGoogle Scholar
  10. [10]
    Bruix J, Llovet JM. Hepatitis B virus and hepatocellular caricnoma[J]. J Hepatol 2003; 39(Suppl 1): S59–S63.CrossRefPubMedGoogle Scholar
  11. [11]
    Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e Antigen and the risk of hepatocellular carcinoma[J]. N Engl J Med 2002; 347: 168–174.CrossRefPubMedGoogle Scholar
  12. [12]
    Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review[J]. Br J Cancer 2007; 96: 1127–1134.CrossRefPubMedGoogle Scholar
  13. [13]
    del Olmo JA, Rodriguez MASF. Incidence and risk factors for hepacellular carcinoma in 967 patients with cirrhosis[J]. J Cancer Res Clin Oncol 1998; 124: 560–564.CrossRefPubMedGoogle Scholar

Copyright information

© Chinese Anti-Cancer Association and Springer Berlin Heidelberg 2009

Authors and Affiliations

  • Zhi-fang Jia
    • 1
  • Meng Su
    • 2
  • Miao He
    • 3
  • Zhi-hua Yin
    • 1
  • Wei Wu
    • 1
  • Xue-lian Li
    • 1
  • Peng Guan
    • 1
  • Bao-sen Zhou
    • 1
  1. 1.Department of Epidemiology and Key Laboratory of Cancer Etiology and Intervention of Liaoning Province, School of Public HealthChina Medical UniversityShenyangChina
  2. 2.Department of Medical OncologyCancer Hospital of Liaoning ProvinceShenyangChina
  3. 3.Information Center, the First Affiliated HospitalChina Medical UniversityShenyangChina

Personalised recommendations